Usefulness of scintigraphy with [99mTc]Tc-DPD for the detection of transthyretin cardiac amyloidosis. Reference centre experience in an endemic area.

30 August 2024 (08:25 - 08:35)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mrs Nuria Orta

Son Espases University Hospital, Palma de Mallorca (Spain)

4 More presentations in this session

Presentation thumbnail

Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records

Doctor L. Anderson (London, GB)

Abstract Slides Video

Presentation thumbnail

Cardiac magnetic resonance T1 imaging for the diagnosis of cardiac amyloidosis among patients with symptomatic heart failure

Doctor R. Gessner (Leipzig, DE)

Abstract Slides Video

Presentation thumbnail

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

Doctor M. Zampieri (Florence, IT)

Abstract Slides Video

Presentation thumbnail

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Mr S. Muller (Utrecht, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiac amyloidosis: my heart is filled with so much…

The Event

Event poster

ESC Congress 2024

30 August 2024 08:25 CET

You may be interested in

Congress Presentation

Impact of increased DPD scintigraphy on timing of diagnosis and prognosis of transthyretin cardiac amyloidosis over the course of ten years

Congress Presentation

Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis

Congress Presentation

DPD quantification correlates with ECV and disease severity in patients with ATTR-CM

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources